Page 2 - ASPIRE AUGUST 2022 Vol 7 Issue 3
P. 2

   Customising the journey of
fertility to each and every family
Over 1 million babies have been born with the help of
Puregon® (Follitropin beta) for over 20 years...1, *
* It is estimated that more than 1 million children have been born after ovarian stimulation and/or ovulation induction with Puregon (rFSH) in assisted reproduction, since it became available.
Reference: 1.GordonK,PrinsM,SchullerK,LewinJ.Onemillionandcounting.ReprodBiomedOnline.2006;13(3):313314.doi:10.1016/s1472-6483(10) 61432-0.
Puregon Selected Safety Information
Precautions Hypothyroidism; adrenocortical insufficiency; hyperprolactinemia; pituitary or hypothalamic tumours; ovarian hyperstimulation syndrome (OHSS); ovarian torsion; thromboembolic events both in association with and separate from OHSS are possible; increased risk of multiplets and adverse maternal and perinatal outcomes; traces of streptomycin or neomycin may cause hypersensitivity reactions. Contraindications For males and females: Hypersensitivity to the active substance or any of the excipients. Tumours of the ovary, breast, uterus, testis, pituitary or hypothalamus. Primary gonadal failure. Additionally for females: Pregnancy or lactation. Undiagnosed vaginal bleeding. Ovarian cysts or enlarged ovaries, not related to polycystic ovarian syndrome (PCOS). Malformations of the reproductive organs incompatible with pregnancy. Fibroid tumours of the uterus incompatible with pregnancy. Adverse Effects Hypersensitivity reactions: (erythaema, urticaria, rash and pruritus observed uncommonly). Female: Headache, abdominal distension, abdominal pain, OHSS, pelvic pain, injection site reaction, ovarian torsion, thromboembolism, unwanted ovarian hyperstimulation and multiple pregnancies. Male: Headache, acne, rash, epididymal cyst, gynecomastia, injection site induration. Please refer to full Product Information for complete list of adverse reactions. Full Prescribing Information is available on request.
Please review the Product Information before prescribing at https::///bbitit.l.yly/3/u3DuDj8jJ8NJN For healthcare professionals only.
Organon Asia Pacific Services Pte Ltd.
150 Beach Road, Gateway West #36-01/08, Singapore 189720 Tel No.: +65-6983 0780 Fax No.: +65-6983 0779
©2022 Organon group of companies. All rights reserved.
ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. SG-PUR-110014 June/2022

   1   2   3   4   5